BioCentury | Nov 25, 2020
Product Development

Data Byte: a snapshot of the clinical cutaneous T cell lymphoma pipeline

...4-hpr) Quisinostat (JNJ-26481585) Suberohydroxamic acid phenyl ester (SHAPE), remetinostat (shp-141, SHAPE) lacutamab (IPH4102) Sofusa anti-PD1 ST-001 nanoFenretinide exoIL-12 TTI-621 (SIRPaFc, SIRPalphaFc) BNZ-1 Cobomarsen (MRG-106) hypericin (HBP-347...
BioCentury | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

...The Human Brain Project (HBP) said Executive Director and Head of the Project Coordination Office Chris...
...HBP." The remarks were made in a joint statement issued Aug. 16 by Ebell and HBP's...
...the Swiss Federal Institute of Technology Lausanne (EPFL). Ebell was promoted to executive director of HBP...
BioCentury | Jan 5, 2018
Financial News

Helix raises C$751K in private placement

...Immuno-oncology company Helix BioPharma Corp. (TSX:HBP) said on Dec. 22, 2017, it raised C$750,600 ($589,863) through...
...a share and a five-year warrant to purchase a share at C$1.50. Helix BioPharma Corp. (TSX:HBP...
BioCentury | Jul 28, 2017
Company News

Helix, Moffitt explore data extraction and checkpoint inhibitors with L-DOS47

...H. Lee Moffitt Cancer Center and Research Institute (Tampa, Fla.) and Helix BioPharma Corp (TSX:HBP) partnered...
...to identify lung adenocarcinoma cells. The partners did not respond to inquiries. Helix BioPharma Corp (TSX:HBP...
BioCentury | Jun 16, 2017
Financial News

Helix raises C$3M in private placement

...On June 7, immuno-oncology company Helix Biopharma Corp. (TSX:HBP) raised C$3 million ($2.3 million) through the...
...a share and a five-year warrant to purchase a share at C$1.50. Helix BioPharma Corp. (TSX:HBP...
BioCentury | Mar 23, 2017
Financial News

Helix completes private placement

...On March 16, immuno-oncology company Helix Biopharma Corp. (TSX:HBP) raised C$1.1 million ($824,780) through the sale...
...a share and a five-year warrant to purchase a share at C$1.50. Helix BioPharma Corp. (TSX:HBP...
BioCentury | Mar 3, 2017
Company News

National Research Council Canada, Helix deal

...did not respond to inquiries. National Research Council Canada (NRC), Ottawa, Ontario Helix BioPharma Corp. (TSX:HBP...
BioCentury | Feb 3, 2017
Clinical News

Hypericin regulatory update

...treat CTCL. Soligenix Inc. (NASDAQ:SNGX), Princeton, N.J. Product: Hypericin ( SGX301 , HBP-347) Business: Cancer Julian Zhu HBP-347 hypericin SGX301 Soligenix...
BioCentury | Dec 30, 2016
Financial News

Helix BioPharma completes private placement

...a share and a five-year warrant to purchase a share at C$1.50. Helix BioPharma Corp. (TSX:HBP...
BioCentury | Sep 5, 2016
Financial News

Helix completes private placement of units

...Helix BioPharma Corp. (TSX:HBP), Aurora, Ontario Business: Drug delivery, Proteomics, Cancer Date completed: 2016-08-19 Type: Private...
Items per page:
1 - 10 of 109